Literature DB >> 15004151

Distinct sequences in the cytoplasmic domain of complement receptor 2 are involved in antigen internalization and presentation.

Denise V Barrault1, Andrew M Knight.   

Abstract

B cells express randomly rearranged surface Ig that forms part of a multiprotein complex known as the B cell receptor (BCR). Recognition of Ag via this receptor results in its capture, internalization, proteolysis and presentation to CD4+ T cells. The recognition of Ag by CD4+ T cells is critical for the selection of individual B cells, leading to the eventual secretion of a high affinity version of the BCR as an effective circulating Ab. B cells also express other receptors that recognize Ags associated with components of innate immunity. One of these receptors, CR2, binds Ags coated with activated complement components. Studies have shown that cross-linking CR2 and the BCR with complement-tagged Ags leads to enhanced Ag presentation by B cells. In addition, Ags targeted to B cell CR2 in the absence of BCR coligation are also efficiently presented to T cells. In this report, we identify several distinct sequences within the cytoplasmic domain of mouse CR2 (mCR2) that are essential for mCR2-mediated Ag presentation in both the presence and the absence of BCR cross-linking. The finding that distinct sequences in the cytoplasmic domain of mCR2 are essential for BCR-independent Ag presentation leads us to propose a novel role for CR2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004151     DOI: 10.4049/jimmunol.172.6.3509

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4(+) T helper type 1 subset differentiation.

Authors:  Caroline L Wilson; Dominic W Hine; Ariel Pradipta; Jeffrey P Pearson; Willem van Eden; John H Robinson; Andrew M Knight
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

Review 2.  Comparative functional evolution of human and mouse CR1 and CR2.

Authors:  Amanda C Jacobson; John H Weis
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

3.  Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205.

Authors:  Carol S Leung; Michael A Maurer; Sonja Meixlsperger; Anne Lippmann; Cheolho Cheong; Jianmin Zuo; Tracey A Haigh; Graham S Taylor; Christian Münz
Journal:  Blood       Date:  2013-01-07       Impact factor: 22.113

4.  Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection.

Authors:  Claire Shannon-Lowe; Martin Rowe
Journal:  PLoS Pathog       Date:  2011-05-05       Impact factor: 6.823

5.  Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection.

Authors:  Suzanne Willey; Marlén M I Aasa-Chapman; Stephen O'Farrell; Pierre Pellegrino; Ian Williams; Robin A Weiss; Stuart J D Neil
Journal:  Retrovirology       Date:  2011-03-14       Impact factor: 4.602

6.  Uptake and presentation of myelin basic protein by normal human B cells.

Authors:  Marie Klinge Brimnes; Bjarke Endel Hansen; Leif Kofoed Nielsen; Morten Hanefeld Dziegiel; Claus Henrik Nielsen
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

7.  High CD21 expression inhibits internalization of anti-CD19 antibodies and cytotoxicity of an anti-CD19-drug conjugate.

Authors:  Gladys S Ingle; Pamela Chan; J Michael Elliott; Wesley S Chang; Hartmut Koeppen; Jean-Philippe Stephan; Suzie J Scales
Journal:  Br J Haematol       Date:  2007-11-07       Impact factor: 6.998

Review 8.  Narrowing the Gap: Preserving Repertoire Diversity Despite Clonal Selection during the CD4 T Cell Response.

Authors:  Julia Merkenschlager; George Kassiotis
Journal:  Front Immunol       Date:  2015-08-11       Impact factor: 7.561

9.  A novel C3d-containing oligomeric vaccine provides insight into the viability of testing human C3d-based vaccines in mice.

Authors:  Yong-Gang He; Isabel Y Pappworth; Andreas Rossbach; Joshua Paulin; Tarirai Mavimba; Christine Hayes; Liudmila Kulik; V Michael Holers; Andrew M Knight; Kevin J Marchbank
Journal:  Immunobiology       Date:  2017-10-04       Impact factor: 3.144

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.